Pharmaceutical Executive interviews Veeva’s vice president, Vault CDMS strategy, Richard Young, and vice president, MyVeeva for Patients strategy, Tim Davis, onsite at DIA Global Annual Meeting 2022 to discuss the industry’s need for holistic digital trials.
They explore the distinction between decentralized and digital trials, how the shift to decentralized trials has impacted the patient experience, and ways to make patient participation in clinical trials easier.
Watch the video to learn what steps the industry can take to remove technology burden on clinical research sites.
Learn how LEO Pharma is achieving faster trials and a better patient experience with Veeva Digital Trials Platform.